Tanya Simuni, MD, was awarded a grant from the National Institutes of Health to conduct a $16 million phase III study of the safety and efficacy of the drug isradipine as a potential neuroprotective agent in Parkinson’s disease.
The team of six students developed a winning business plan for a patented, personalized therapy that stimulates the immune system to fight breast cancer.
Study is the first to show sedentary behavior is its own risk factor for disability, separate from lack of moderate vigorous physical activity.
The degree program offers tools needed to become a leader in global healthcare and address some of the most important, far-reaching and urgent health issues of the 21st century.
Elevated blood pressure as young as age 18 is a warning sign of cardiovascular disease developing later in life and the time to begin prevention. That’s decades earlier than clinicians and patients generally start thinking about heart disease risk.
According to a new study, memory rewrites the past with current information, updating your recollections with new experiences.
After a heart attack, much of the damage to the heart muscle is caused by inflammatory cells that rush to the scene of the oxygen-starved tissue. But the damage is slashed in half when microparticles are injected into the blood stream within 24 hours of the attack, according to preclinical research.
Teens who were heavy marijuana users – smoking it daily for about three years – had abnormal changes in their brain structures related to working memory and performed poorly on memory tasks, reports a new Northwestern Medicine study.
New national guidelines change the focus from aiming strictly at reducing bad cholesterol to a more personalized approach.
Study published in the American Journal of Psychiatry by Crystal Clark, MD, assistant professor of psychiatry and behavioral sciences, shows the blood concentration of the commonly used drug lamotrigine decreases in pregnant women.